Most Recent
A judge has rejected part of IVF provider Virtus Health’s bid for redactions in a recent decision from the court temporarily blocking the company from purchasing rival Adora Fertility, saying some of the confidentiality claims were “staggering” and “border on ridiculous.”
A judge has declined to quash the indictment in a high-profile criminal case over a $2.5 billion ANZ share placement but sent prosecutors back to the drawing board to remedy its defects, calling the state of affairs "a complete shemozzle".
A judge has ordered a class action against AMP to provide more detail in its case accusing the financial services firm of failing to disclose information to shareholders about allegedly misleading ASIC and charging clients fees for no service.
Thomson Geer is giving all staff a 10 per cent pay bump, less than a week after Big Six law firm Gilbert + Tobin announced similar measures amid tight competition for talent in the legal market.
Corrs Chambers Westgarth has continued its hiring spree, luring a financial services regulatory specialist from Herbert Smith Freehills.
A judge has given the green light to amended pleadings in a class action accusing major banks of entering a cartel agreement to rig foreign exchange rates, bringing a two-year fight over the pleadings closer to resolution.
Legislation capping litigation funder returns in class actions to 30 per cent and requiring group members to sign up to funding schemes has been introduced to federal parliament despite widespread criticism.
Infrastructure developers Lendlease and Acciona are suing each other for tens of millions of dollars over alleged losses stemming from Acciona's $160 million acquisition of Lendlease's engineering business, which saw it take over the Gawler rail project in South Australia.
The Australian Competition and Consumer Commission has won an injunction to stop Virtus from completing the purchase of rival Adora Fertility until a court has ruled on the competition regulator's challenge to the acquisition.
IVF provider Virtus Health would be “the author of its own fate” if its proposed acquisition of rival Adora Fertility flopped, a judge has said in hearing the ACCC’s bid for a temporary injunction blocking completion of the planned purchase.